Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:26:56.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain elements related to medical and healthcare publications or documentation. This change may reflect an increase in the count of specific study records or related data entries.
    Difference
    0.3%
    Check dated 2024-05-22T21:15:41.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:28:50.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.